CTDSP2

CTD small phosphatase 2, the group of CTD family phosphatases|MicroRNA protein coding host genes

Basic information

Region (hg38): 12:57819927-57846729

Links

ENSG00000175215NCBI:10106OMIM:608711HGNC:17077Uniprot:O14595AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the CTDSP2 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the CTDSP2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
1
missense
9
clinvar
9
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
3
clinvar
3
Total 0 0 12 1 0

Variants in CTDSP2

This is a list of pathogenic ClinVar variants found in the CTDSP2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
12-57823627-C-G not specified Uncertain significance (Oct 07, 2024)3498144
12-57823632-G-A CTDSP2-related disorder Likely benign (Nov 06, 2020)3033573
12-57823637-C-T not specified Uncertain significance (Apr 04, 2024)3270051
12-57823650-G-A CTDSP2-related disorder Likely benign (Nov 06, 2020)3034914
12-57823671-G-T CTDSP2-related disorder Likely benign (Nov 06, 2020)3051125
12-57823700-T-G not specified Uncertain significance (Oct 06, 2021)3078602
12-57823973-C-A EBV-positive nodal T- and NK-cell lymphoma Likely benign (-)2681221
12-57824043-C-T not specified Uncertain significance (Oct 09, 2024)3498146
12-57824059-G-A not specified Uncertain significance (Dec 12, 2024)3837118
12-57824266-T-A not specified Uncertain significance (May 08, 2023)2544951
12-57826355-G-A Likely benign (Jun 23, 2018)755992
12-57827556-T-C not specified Uncertain significance (Nov 06, 2023)3078601
12-57827557-A-G not specified Uncertain significance (Feb 27, 2025)3837117
12-57827589-G-A not specified Uncertain significance (Oct 25, 2024)3498145
12-57829464-G-T not specified Uncertain significance (Jun 04, 2024)3270052
12-57829525-G-C not specified Uncertain significance (Nov 10, 2024)3498148
12-57829560-C-A not specified Uncertain significance (Jul 22, 2024)3498147
12-57829584-T-C not specified Uncertain significance (Aug 15, 2023)2619286
12-57846413-G-A not specified Uncertain significance (Jun 16, 2024)3270053

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
CTDSP2protein_codingprotein_codingENST00000398073 826813
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.1140.880124857071248640.0000280
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.511071610.6660.000009131761
Missense in Polyphen2360.7210.37878693
Synonymous0.7965664.10.8730.00000365537
Loss of Function2.43413.70.2915.81e-7165

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00002900.0000290
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.00004420.0000441
Middle Eastern0.000.00
South Asian0.00003270.0000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Preferentially catalyzes the dephosphorylation of 'Ser- 5' within the tandem 7 residue repeats in the C-terminal domain (CTD) of the largest RNA polymerase II subunit POLR2A. Negatively regulates RNA polymerase II transcription, possibly by controlling the transition from initiation/capping to processive transcript elongation. Recruited by REST to neuronal genes that contain RE-1 elements, leading to neuronal gene silencing in non-neuronal cells. May contribute to the development of sarcomas. {ECO:0000269|PubMed:12721286, ECO:0000269|PubMed:15681389}.;
Pathway
TGF-Ncore;XBP1(S) activates chaperone genes;BMP receptor signaling;Coregulation of Androgen receptor activity;Regulation of cytoplasmic and nuclear SMAD2/3 signaling (Consensus)

Recessive Scores

pRec
0.154

Intolerance Scores

loftool
0.464
rvis_EVS
-0.23
rvis_percentile_EVS
36.86

Haploinsufficiency Scores

pHI
0.495
hipred
Y
hipred_score
0.529
ghis
0.612

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.968

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Ctdsp2
Phenotype
cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);

Gene ontology

Biological process
negative regulation of protein phosphorylation;regulation of transcription by RNA polymerase II;protein dephosphorylation;IRE1-mediated unfolded protein response;negative regulation of G1/S transition of mitotic cell cycle
Cellular component
nucleoplasm
Molecular function
phosphoprotein phosphatase activity;protein binding;RNA polymerase II CTD heptapeptide repeat phosphatase activity;metal ion binding